![Peter DeMuth](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Peter DeMuth
Directeur Technique/Scientifique/R&D chez ELICIO THERAPEUTICS, INC.
Fortune : - $ au 31/05/2024
Postes actifs de Peter DeMuth
Sociétés | Poste | Début | Fin |
---|---|---|---|
ELICIO THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 01/01/2022 | - |
Historique de carrière de Peter DeMuth
Anciens postes connus de Peter DeMuth
Sociétés | Poste | Début | Fin |
---|---|---|---|
Elicio Therapeutics, Inc. (Old)
![]() Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA. | Directeur Technique/Scientifique/R&D | 01/08/2017 | 01/06/2023 |
Formation de Peter DeMuth
Massachusetts Institute of Technology | Doctorate Degree |
University of Maryland | Undergraduate Degree |
Statistiques
Internationale
Etats-Unis | 5 |
Opérationnelle
Chief Tech/Sci/R&D Officer | 2 |
Doctorate Degree | 1 |
Undergraduate Degree | 1 |
Sectorielle
Health Technology | 3 |
Finance | 2 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
ELICIO THERAPEUTICS, INC. | Health Technology |
Entreprise privées | 1 |
---|---|
Elicio Therapeutics, Inc. (Old)
![]() Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA. | Health Technology |
- Bourse
- Insiders
- Peter DeMuth
- Expérience